Abraxis BioScience - Ownership and Business Overview

Life ScienceCompany

Abraxis BioScience Ownership

Who owns Abraxis BioScience?

Abraxis BioScience is owned by Celgene. It was acquired on June 30, 2010.

Abraxis BioScience Business Overview

Where is Abraxis BioScience headquartered?

Abraxis BioScience is headquartered in Los Angeles, California.

How many employees does Abraxis BioScience have?

Abraxis BioScience has 885 employees.

What sector is Abraxis BioScience in?

Abraxis BioScience is a life science company.

When was Abraxis BioScience founded?

Abraxis BioScience was founded in 2007.

Life Science M&A Summary in 2010

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.

Join Mergr to view all 138 acquisitions of life science companies in 2010, including 15 acquisitions by private equity firms, and 123 by strategics.

Abraxis BioScience, Inc.

11755 Wilshire Boulevard, Suite 2000,
Los Angeles, California 90025
United States,
(310) 883-1300
www.abraxisbio.com

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes chemotherapeutic compound (ABRAXANE), which is based on the company's proprietary tumor targeting technology known as the nab® platform. The first FDA approved product to use this nab platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer and is now approved in 39 countries. The company continues to expand the nab platform through a robust clinical program and deep product pipeline.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.